<antigenSupportingData>
<immunity>
<clinicalHistory>
<guidelineCode>018</guidelineCode>
<guidelineTitle>Laboratory Evidence of Immunity or confirmation of Hepatitis A disease</guidelineTitle>
</clinicalHistory>
</immunity>
<contraindications>
<vaccineGroup>
<contraindication>
<observationCode>080</observationCode>
<observationTitle>Adverse reaction to vaccine component</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had an adverse reaction to a vaccine component.</contraindicationText>
<contraindicationGuidance/>
<beginAge/>
<endAge/>
</contraindication>
<contraindication>
<observationCode>096</observationCode>
<observationTitle>Severe allergic reaction after previous dose of Hepatitis A</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had a severe allergic reaction after a previous dose of Hepatitis A vaccine.</contraindicationText>
<contraindicationGuidance/>
<beginAge/>
<endAge/>
</contraindication>
<contraindication>
<observationCode>107</observationCode>
<observationTitle>Severe allergic reaction to neomycin</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had a severe allergic reaction to neomycin.</contraindicationText>
<contraindicationGuidance/>
<beginAge/>
<endAge/>
</contraindication>
<contraindication>
<observationCode>112</observationCode>
<observationTitle>Hypersensitivity to alum</observationTitle>
<contraindicationText>Do not vaccinate if the patient has a hypersensitivity to alum.</contraindicationText>
<contraindicationGuidance/>
<beginAge/>
<endAge/>
</contraindication>
</vaccineGroup>
<vaccine>
<contraindication>
<observationCode>110</observationCode>
<observationTitle>Hypersensitivity to yeast</observationTitle>
<contraindicationText>Do not vaccinate if the patient has a hypersensitivity to yeast.</contraindicationText>
<contraindicationGuidance/>
<contraindicatedVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge/>
<endAge/>
</contraindicatedVaccine>
</contraindication>
</vaccine>
</contraindications>
<series>
<seriesName>HepA 2-dose series</seriesName>
<targetDisease>HepA</targetDisease>
<vaccineGroup>HepA</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Standard</seriesType>
<equivalentSeriesGroups>2</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>Yes</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Standard</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>1</seriesPreference>
<minAgeToStart/>
<maxAgeToStart>19 years</maxAgeToStart>
</selectSeries>
<indication/>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>12 months - 4 days</absMinAge>
<minAge>12 months</minAge>
<earliestRecAge>12 months</earliestRecAge>
<latestRecAge>24 months + 4 weeks</latestRecAge>
<maxAge>19 years</maxAge>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep A, adult</vaccineType>
<cvx>52</cvx>
<beginAge>19 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep A, ped/adol, 2 dose</vaccineType>
<cvx>83</cvx>
<beginAge>12 months</beginAge>
<endAge>19 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep A, pediatric, Unspecified</vaccineType>
<cvx>31</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge>19 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep A, adult</vaccineType>
<cvx>52</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep A, ped/adol, 2 dose</vaccineType>
<cvx>83</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge>19 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep A, Unspecified</vaccineType>
<cvx>85</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge>19 years</endAge>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge>18 months - 4 days</absMinAge>
<minAge>18 months</minAge>
<earliestRecAge>18 months</earliestRecAge>
<latestRecAge>24 months + 4 weeks</latestRecAge>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>6 months - 4 days</absMinInt>
<minInt>6 months</minInt>
<earliestRecInt>6 months</earliestRecInt>
<latestRecInt>19 months + 4 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<absMinInt>6 months</absMinInt>
<effectiveDate/>
<cessationDate/>
</allowableInterval>
<preferableVaccine>
<vaccineType>Hep A, adult</vaccineType>
<cvx>52</cvx>
<beginAge>19 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep A, ped/adol, 2 dose</vaccineType>
<cvx>83</cvx>
<beginAge>12 months</beginAge>
<endAge>19 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep A, pediatric, Unspecified</vaccineType>
<cvx>31</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge>19 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep A, adult</vaccineType>
<cvx>52</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep A, ped/adol, 2 dose</vaccineType>
<cvx>83</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge>19 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep A, Unspecified</vaccineType>
<cvx>85</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge>19 years</endAge>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>HepA risk 1-dose series</seriesName>
<targetDisease>HepA</targetDisease>
<vaccineGroup>HepA</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups/>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>3</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>1</seriesPreference>
<minAgeToStart>6 months</minAgeToStart>
<maxAgeToStart>12 months</maxAgeToStart>
</selectSeries>
<indication>
<observationCode>
<text>Travelling Internationally</text>
<code>048</code>
</observationCode>
<description>Administer to persons who will be travelling internationally.</description>
<beginAge>6 months</beginAge>
<endAge>12 months</endAge>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>6 months - 4 days</absMinAge>
<minAge>6 months</minAge>
<earliestRecAge>6 months</earliestRecAge>
<latestRecAge>12 months</latestRecAge>
<maxAge>12 months</maxAge>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep A, ped/adol, 2 dose</vaccineType>
<cvx>83</cvx>
<beginAge>12 months</beginAge>
<endAge>19 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep A, pediatric, Unspecified</vaccineType>
<cvx>31</cvx>
<beginAge>6 months - 4 days</beginAge>
<endAge>19 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep A, adult</vaccineType>
<cvx>52</cvx>
<beginAge>6 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep A, ped/adol, 2 dose</vaccineType>
<cvx>83</cvx>
<beginAge>6 months - 4 days</beginAge>
<endAge>19 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep A, Unspecified</vaccineType>
<cvx>85</cvx>
<beginAge>6 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>6 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>HepA risk 2-dose series</seriesName>
<targetDisease>HepA</targetDisease>
<vaccineGroup>HepA</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups>1</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>1</seriesPreference>
<minAgeToStart>19 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Patient seeks protection</text>
<code>001</code>
</observationCode>
<description>Administer to persons seeking protection.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Receives clotting factor concentrates</text>
<code>006</code>
</observationCode>
<description>Administer to persons who receive clotting factor concentrates.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Chronic liver disease</text>
<code>015</code>
</observationCode>
<description>Administer to persons who have chronic liver disease.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Men who have sex with men</text>
<code>036</code>
</observationCode>
<description>Administer to men who have sex with men.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Illicit drug use</text>
<code>040</code>
</observationCode>
<description>Administer to persons who use illicit drugs.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Close contact with international adoptee during first 60 days</text>
<code>044</code>
</observationCode>
<description>Administer to persons who will have close contact with an international adoptee during the first 60 days.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance>The first dose of the 2-dose hepatitis A vaccine series should be administered as soon as adoption is planned, ideally 2 or more weeks before the arrival of the adoptee.</guidance>
</indication>
<indication>
<observationCode>
<text>Working with Hepatitis A virus in research setting</text>
<code>049</code>
</observationCode>
<description>Administer to persons who work with Hepatitis A virus in a research setting.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Occupational exposure for Hepatitis A</text>
<code>059</code>
</observationCode>
<description>Administer to persons who have an occupational exposure for Hepatitis A</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Homelessness</text>
<code>121</code>
</observationCode>
<description>Administer to persons who are experiencing homelessness.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Travel to or working in countries that have high or intermediate endemicity of Hepatitis A</text>
<code>142</code>
</observationCode>
<description>Administer to persons traveling to or working in countries that have high or intermediate endemicity of Hepatitis A.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV/AIDS - severely immunocompromised</text>
<code>154</code>
</observationCode>
<description>Administer to persons who have HIV/AIDS and are severely immunocompromised [See the CDC general recommendations for a definition of "severely immunocompromised"].</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV/AIDS - not severely immunocompromised</text>
<code>155</code>
</observationCode>
<description>Administer to persons who have HIV/AIDS and are not severely immunocompromised [See the CDC general recommendations for a definition of "severely immunocompromised"].</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Patient seeks Hepatitis A  protection</text>
<code>175</code>
</observationCode>
<description>Administer to persons seeking protection from Hepatitis A.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>12 months - 4 days</absMinAge>
<minAge>12 months</minAge>
<earliestRecAge>12 months</earliestRecAge>
<latestRecAge>24 months + 4 weeks</latestRecAge>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep A, adult</vaccineType>
<cvx>52</cvx>
<beginAge>19 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep A, ped/adol, 2 dose</vaccineType>
<cvx>83</cvx>
<beginAge>12 months</beginAge>
<endAge>19 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep A, pediatric, Unspecified</vaccineType>
<cvx>31</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge>19 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep A, adult</vaccineType>
<cvx>52</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep A, ped/adol, 2 dose</vaccineType>
<cvx>83</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge>19 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep A, Unspecified</vaccineType>
<cvx>85</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>6 months - 4 days</absMinInt>
<minInt>6 months</minInt>
<earliestRecInt>6 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<absMinInt>6 months</absMinInt>
<effectiveDate/>
<cessationDate/>
</allowableInterval>
<preferableVaccine>
<vaccineType>Hep A, adult</vaccineType>
<cvx>52</cvx>
<beginAge>19 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep A, pediatric, Unspecified</vaccineType>
<cvx>31</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge>19 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep A, adult</vaccineType>
<cvx>52</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep A, ped/adol, 2 dose</vaccineType>
<cvx>83</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge>19 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep A, Unspecified</vaccineType>
<cvx>85</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>HepA risk Twinrix 3 dose series</seriesName>
<targetDisease>HepA</targetDisease>
<vaccineGroup>HepA</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups>1</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>Yes</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>2</seriesPreference>
<minAgeToStart>19 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Patient seeks protection</text>
<code>001</code>
</observationCode>
<description>Administer to persons seeking protection.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Receives clotting factor concentrates</text>
<code>006</code>
</observationCode>
<description>Administer to persons who receive clotting factor concentrates.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Chronic liver disease</text>
<code>015</code>
</observationCode>
<description>Administer to persons who have chronic liver disease.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Men who have sex with men</text>
<code>036</code>
</observationCode>
<description>Administer to men who have sex with men.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Illicit drug use</text>
<code>040</code>
</observationCode>
<description>Administer to persons who use illicit drugs.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Close contact with international adoptee during first 60 days</text>
<code>044</code>
</observationCode>
<description>Administer to persons who will have close contact with an international adoptee during the first 60 days.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance>The first dose of the 2-dose hepatitis A vaccine series should be administered as soon as adoption is planned, ideally 2 or more weeks before the arrival of the adoptee.</guidance>
</indication>
<indication>
<observationCode>
<text>Working with Hepatitis A virus in research setting</text>
<code>049</code>
</observationCode>
<description>Administer to persons who work with Hepatitis A virus in a research setting.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Occupational exposure for Hepatitis A</text>
<code>059</code>
</observationCode>
<description>Administer to persons who have an occupational exposure for Hepatitis A</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Homelessness</text>
<code>121</code>
</observationCode>
<description>Administer to persons who are experiencing homelessness.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Travel to or working in countries that have high or intermediate endemicity of Hepatitis A</text>
<code>142</code>
</observationCode>
<description>Administer to persons traveling to or working in countries that have high or intermediate endemicity of Hepatitis A.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV/AIDS - severely immunocompromised</text>
<code>154</code>
</observationCode>
<description>Administer to persons who have HIV/AIDS and are severely immunocompromised [See the CDC general recommendations for a definition of "severely immunocompromised"].</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV/AIDS - not severely immunocompromised</text>
<code>155</code>
</observationCode>
<description>Administer to persons who have HIV/AIDS and are not severely immunocompromised [See the CDC general recommendations for a definition of "severely immunocompromised"].</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Patient seeks Hepatitis A  protection</text>
<code>175</code>
</observationCode>
<description>Administer to persons seeking protection from Hepatitis A.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>18 years - 4 days</absMinAge>
<minAge>18 years</minAge>
<earliestRecAge>18 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep A, pediatric, Unspecified</vaccineType>
<cvx>31</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge>19 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep A, adult</vaccineType>
<cvx>52</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep A, ped/adol, 2 dose</vaccineType>
<cvx>83</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge>19 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep A, Unspecified</vaccineType>
<cvx>85</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep A, pediatric, Unspecified</vaccineType>
<cvx>31</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge>19 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep A, adult</vaccineType>
<cvx>52</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep A, ped/adol, 2 dose</vaccineType>
<cvx>83</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge>19 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep A, Unspecified</vaccineType>
<cvx>85</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>5 months - 4 days</absMinInt>
<minInt>5 months</minInt>
<earliestRecInt>5 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>6 months - 4 days</absMinInt>
<minInt>6 months</minInt>
<earliestRecInt>6 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep A, pediatric, Unspecified</vaccineType>
<cvx>31</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge>19 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep A, adult</vaccineType>
<cvx>52</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep A, ped/adol, 2 dose</vaccineType>
<cvx>83</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge>19 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep A, Unspecified</vaccineType>
<cvx>85</cvx>
<beginAge>12 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>HepA risk Twinrix 4 dose Series</seriesName>
<targetDisease>HepA</targetDisease>
<vaccineGroup>HepA</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups>1</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>Yes</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>3</seriesPreference>
<minAgeToStart>19 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Patient seeks protection</text>
<code>001</code>
</observationCode>
<description>Administer to persons seeking protection.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Receives clotting factor concentrates</text>
<code>006</code>
</observationCode>
<description>Administer to persons who receive clotting factor concentrates.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Chronic liver disease</text>
<code>015</code>
</observationCode>
<description>Administer to persons who have chronic liver disease.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Men who have sex with men</text>
<code>036</code>
</observationCode>
<description>Administer to men who have sex with men.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Illicit drug use</text>
<code>040</code>
</observationCode>
<description>Administer to persons who use illicit drugs.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Close contact with international adoptee during first 60 days</text>
<code>044</code>
</observationCode>
<description>Administer to persons who will have close contact with an international adoptee during the first 60 days.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance>The first dose of the 2-dose hepatitis A vaccine series should be administered as soon as adoption is planned, ideally 2 or more weeks before the arrival of the adoptee.</guidance>
</indication>
<indication>
<observationCode>
<text>Working with Hepatitis A virus in research setting</text>
<code>049</code>
</observationCode>
<description>Administer to persons who work with Hepatitis A virus in a research setting.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Occupational exposure for Hepatitis A</text>
<code>059</code>
</observationCode>
<description>Administer to persons who have an occupational exposure for Hepatitis A</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Homelessness</text>
<code>121</code>
</observationCode>
<description>Administer to persons who are experiencing  homelessness.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Travel to or working in countries that have high or intermediate endemicity of Hepatitis A</text>
<code>142</code>
</observationCode>
<description>Administer to persons traveling to or working in countries that have high or intermediate endemicity of Hepatitis A.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV/AIDS - severely immunocompromised</text>
<code>154</code>
</observationCode>
<description>Administer to persons who have HIV/AIDS and are severely immunocompromised [See the CDC general recommendations for a definition of "severely immunocompromised"].</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV/AIDS - not severely immunocompromised</text>
<code>155</code>
</observationCode>
<description>Administer to persons who have HIV/AIDS and are not severely immunocompromised [See the CDC general recommendations for a definition of "severely immunocompromised"].</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Patient seeks Hepatitis A  protection</text>
<code>175</code>
</observationCode>
<description>Administer to persons seeking protection from Hepatitis A.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>18 years - 4 days</absMinAge>
<minAge>18 years</minAge>
<earliestRecAge>18 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>7 days</absMinInt>
<minInt>7 days</minInt>
<earliestRecInt>7 days</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>14 days</absMinInt>
<minInt>14 days</minInt>
<earliestRecInt>14 days</earliestRecInt>
<latestRecInt>23 days</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 4</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>12 months - 4 days</absMinInt>
<minInt>12 months</minInt>
<earliestRecInt>12 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
</antigenSupportingData>
